Regulation of tumor growth and metastasis by thrombospondin-1

FASEB Journal

Volumn 10, Issue 10, 1996, Pages 1183-1191

  Roberts, David D ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

angiogenesis; cell matrix interactions; tumorigenesis

Indexed keywords

THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; CELL ADHESION; CELL GROWTH; CELL SURFACE; GROWTH REGULATION; HUMAN; METASTASIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0029797025     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.10.8751720     Document Type: Review

References (69)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31
2. Stracke, M. L., Murata, J., Aznavoorian, S., and Liotta, L. A. (1994) The role of the extracellular matrix in tumor cell metastasis. In Vivo 8, 49-58
3. Albelda, S. M. (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68, 4-17
4. Bornstein, P. (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130, 503-506
5. Lahav, J. (1993) Thrombospondin, 298 pp., CRC Press, Boca Raton, Florida
6. Adams, J., and Lawler, J. (1993) The thrombospondin family. Curr. Biol. 3, 188-190
7. Lahav, J. (1993) The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim. Biophys. Acta 1182, 1-14
8. Bornstein, P. (1992) Thrombospondins: structure and regulation of expression. FASEB J. 6, 3290-3299
9. Zabrenetzky, V., Harris, C. C, Steeg, P. S., and Roberts, D. D. (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59, 191-195
10. Zajchowski, D. A., Band, V., Trask, D. K., Kling, D., Connolly, J. L., and Sager, R. (1990) Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc. Natl. Acad. Sci. USA 87, 2314-2318
11. Yabkowitz, R., Mansfield, P. J., Dixit, V. M., and Suchard, S. J. (1993) Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains. Cancer Res, 53, 378-387
12. Salnikow, K., Cosentino, S., Klein, C., and Costa, M. (1994) Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol. Cell. Biol. 14, 851-858
13. RayChaudhury, A., Frazier, W. A., and D'Amore, P. A. (1994) Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta. J. Cell Sci. 107, 39-46
14. Volpert, O. V., Stellmach, V., and Bouck, N. (1995) The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat. 36, 119-126
15. Weinstat-Saslow, D. L., Zabrenetzky, V. S., VanHoulte, K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511
16. Sheibani, N., and Frazier, W. A, (1995) Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl. Acad. Sci. USA 92, 6788-6792
17. Castle, V., Varani, J., Fligiel, S., Prochownik, E. V., and Dixit, V. (1991) Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J. Clin. Invest. 87, 1883-1888
18. Castle, V. P., Ou, X., O'Rourke, K., and Dixit, V. M. (1993) High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers senimand anchorage-independent growth. J. Biol. Chem. 268, 2899-2903
19. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584
20. Tuszynski, G. P., and Nicosia, R. F. (1996) The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays 18, 71-76
21. Clark, E. A., and Brugge, J. S. (1995) Integrins and signal transduction pathways: the road taken. Science 268, 233-239
22. Yamada, K. M. (1991) Adhesive recognition sequences. J. Biol. Chem. 266, 12809-12812
23. Lawler, J. (1993) The interactions of thrombospondin with integrins. In Thrombospondin (Lahav, J., ed) pp. 275-282, CRC Press, Boca Raton, Florida
24. DeFreitas, M. F., Yoshida, C. K., Frazier, W. A., Mendrick, D. L., Kypta, R. M., and Reichardt, L. F. (1995) Identification of integrin alpha 3 beta 1 as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron 15, 333-343
25. Yabkowitz, R., Dixit, V. M., Guo, N., Roberts, D. D., and Shimizu, Y. (1993) Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins. J. Immunol. 151, 149-158
26. Tsao, P. W., and Mousa, S. A. (1995) Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains. J. Biol. Chem. 270, 23747-23753
27. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164
28. Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., and Frazier, W. A. (1996) Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271, 21-24
29. Asch, A. S. (1993) The role of CD36 as a thrombospondin receptor. In Thrombospondin (Lahav, J., ed) pp. 265-273, CRC Press, Boca Raton, Florida
30. Asch, A. S., Liu, I., Briccetti, F. M., Barnwell, J. W., Kwakye-Berko, F., Dokun, A., Goldberger, J., and Pernambuco, M. (1993) Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science 262, 1436-1440
31. Silverstein, R. L., Baird, M., Lo, S. K., and Yesner, L. M. (1992) Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J. Biol. Chem. 267, 16607-16612
32. Clezardin, P., Frappart, L., Clerget, M., Pechoux, C., and Delmas, P. D. (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res. 53, 1421-1430
33. Mikhailenko, I., Kounnas, M. Z., and Strickland, D. K. (1995) Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans. J. Biol. Chem. 270, 9543-9549
34. Godyna, S., Liau, G., Popa, I., Stefansson, S., and Argraves, W. S. (1905) Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J. Cell Biol. 129, 1403-1410
35. Yabkowitz, R., and Dixit, V. M. (1991) Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. Cancer Res. 51, 3648-3656
36. Roberts, D. D. (1993) Interactions of thrombospondin with sulfatides and other sulfated glyconjugates. In Thrombospondin (Lahav, J., ed) pp. 73-90, CRC Press, Boca Raton, Florida
37. Taraboletti, C., Roberts, D., Liotta, L. A., and Giavazzi, R. (1990) Platelet thrombospondin modulates endothelial cell adhesion, motilily, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111, 765-772
38. Vogel, T., Guo, N. H., Krutzsch, H. C., Blake, D. A., Hartman, J., Mendelovitz, S., Panet, A., and Roberts, D. D. (1993) Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J. Cell. Biochem. 53, 74-84
39. Murphy-Ullrich, J. E., Schultz Cherry, S., and Höök, M. (1992)Transforming growth factor-beta complexes with thrombospondin. Mal. Biol. Cell 3, 181-188
40. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Kratzseh, H. C., Roberts, D. D., and Murphy-Ullrich, J. E. (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270, 7304-7310
41. Souchelnitskiy, S., Chambaz, E. M., and Feige, J. J. (1995) Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium. Endocrinology 136, 5118-5126
42. Hogg, P. J. (1994) Thrombospondin 1 as an enzyme inhibitor. Thromb. Haemost. 72, 787-792
43. Hosokawa, T., Muraishi, A., Rothman, V. L., Papale, M., and Tuszynski, G. P. (1993) The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncol. Res. 5, 183-189
44. Bagavandoss, P., Kaytes, P., Vogeli, G., Wells, P. A., and Wilks, J. W. (1993) Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. Biochem. Biophys. Res. Commun. 192, 325-332
45. Riser, B. L., Varani, J., O'Rourke, K., and Dixit, V. M. (1988) Thrombospondin binding by human squamous carcinoma and melanoma cells: relationship to biological activity. Exp. Cell Res. 174, 319-329
46. Tuszynski, G. P., and Nicosia, R. F. (1994) Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab. Invest. 70, 228-233
47. Wong, S. Y., Purdie, A. T., and Han, P. (1992) Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. Am. J. Pathol. 140, 1473-1402
48. Serre, C. M., Clezardin, P., Frappart, L., Boivin, G., and Delmas, P. D. (1995) Distribution of thrombospondin and integrin alpha(v) in DCIS, invasive ductal and lobular human breast carcinomas-analysis by electron-microscopy. Virchows Arch. 427, 365-372
49. Baley, P., Lutzelschwab, I., Scott-Burden, T., Kung, W., and Eppenberger, U. (1990) Modulation of extracellular-matrix synthesized by cultured stromal cells from normal human breast tissue by epidermal growth factor. J. Cell. Biochem. 43, 111-125
50. Si, Z., and Hersey, P. (1994) Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and "selectins" on melanoma cells. Pathology 26, 6-15
51. Honn, K. V., Tang, D. G., and Crissman, J. D. (1992) Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 11, 325-351
52. Katagiri, Y., Hayashi, Y., Baba, I., Suzuki, H., Tanoue, K., and Yamazaki, H. (1991) Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins. Cancer Res. 51, 1286-1293
53. Boukerche, H., Berthier-Vergnes, O., Tabone, E., Bailly, M., Dore, J. F., and McGregor, J. L. (1995) Thrombospondin modulates melanoma - platelet interactions and melanoma tumour cell growth in vivo. Br. J. Cancer 72, 108-116
54. Incardona, F., Lewalle, J. M., Morandi, V., Lambert, S., Legrand, Y., Foidart, J. M., and Legrand, C. (1995) Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res. 55, 166-173
55. Taraboletti, G., Roberts, D. D., and Liotta, L. A. (1987) Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J. Cell Biol. 105, 2409-2415
56. Murphy-Ullrich, J. E., and Höök, M. (1989) Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 109, 1309-1319
57. Murphy-Ullrich, J. E., Gurusiddappa, S., Frazier, W. A., and Höök, M. (1993) Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem. 268, 26784-26789
58. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122, 497-511
59. DiPietro, L. A., Nebgen, D. R., and Polverini, P. J. (1994) Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J. Vasc. Res. 31, 178-185
60. Good, D. J., Polverini, P. J., Rastinejad, F., Le, B. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628
61. BenEzra, D., Griffin, B. W., Maftzir, G., and Aharonov, O. (1993) Thromhospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest. Ophthalmol. Vis. Sci. 34, 3601-3608
62. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528
63. Riser, B. L., Mitra, R., Perry, D., Dixit, V., and Varani, J. (1989) Monocyte killing of human squamous epithelial cells: role for thrombospondin. Cancer Res. 49, 6123-6129
64. Suchard, S. J. (1993) Interaction of human neutrophils and HL-60 cells with the extracellular matrix. Blood Cells 19, 197-221
65. Savill, J., Hogg, N., Ren, Y., and Haslett, C. (1992) Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513-1522
66. Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., and Forbes, J. T. (1993) Anti-transforming growth factor (TCF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. J. Clin. Invest. 92, 2569-2576
67. Pierson, B. A., Gupta, K., Hu, W.-S., and Miller, J. S. (1996) Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor beta-1 and independent accessory cell-derived contact and soluble factors. Blood 87, 180-189
68. Phan, S. H., Dillon, R. G., McGarry, B. M., and Dixit, V. M. (1989) Stimulation of fibroblast proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 163, 56-63
69. Iruela-Arispe, M. L., Porter, P., Bornstein, P., and Sage, E. II. (1996) Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest. 97, 403-412